ATE465744T1 - Ifosfamid-zusammensetzungen zur parenteralen verabreichung und verfahren für ihre herstellung - Google Patents
Ifosfamid-zusammensetzungen zur parenteralen verabreichung und verfahren für ihre herstellungInfo
- Publication number
- ATE465744T1 ATE465744T1 AT03808347T AT03808347T ATE465744T1 AT E465744 T1 ATE465744 T1 AT E465744T1 AT 03808347 T AT03808347 T AT 03808347T AT 03808347 T AT03808347 T AT 03808347T AT E465744 T1 ATE465744 T1 AT E465744T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions
- preparation
- ifosfamid
- methods
- parenteral administration
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001101 ifosfamide Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000007911 parenteral administration Methods 0.000 title 1
- XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 abstract 1
- 229960004635 mesna Drugs 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN785MU2002 | 2002-12-02 | ||
| PCT/IN2003/000376 WO2004050012A2 (en) | 2002-12-02 | 2003-12-02 | Ifosfamide compositions for parenteral administration and a process for their preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE465744T1 true ATE465744T1 (de) | 2010-05-15 |
Family
ID=32448836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03808347T ATE465744T1 (de) | 2002-12-02 | 2003-12-02 | Ifosfamid-zusammensetzungen zur parenteralen verabreichung und verfahren für ihre herstellung |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1569663B1 (de) |
| JP (1) | JP4611029B2 (de) |
| KR (1) | KR101066181B1 (de) |
| CN (1) | CN100463678C (de) |
| AT (1) | ATE465744T1 (de) |
| AU (1) | AU2003302579B2 (de) |
| BR (1) | BR0316968A (de) |
| CA (1) | CA2507848A1 (de) |
| DE (1) | DE60332385D1 (de) |
| EA (1) | EA012368B1 (de) |
| ES (1) | ES2342380T3 (de) |
| IL (1) | IL168849A (de) |
| MX (1) | MXPA05005919A (de) |
| NZ (1) | NZ540484A (de) |
| WO (1) | WO2004050012A2 (de) |
| ZA (1) | ZA200504437B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102573500A (zh) | 2009-08-06 | 2012-07-11 | 纽拉尔图斯制药公司 | 巨噬细胞相关疾病的治疗 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0241469B1 (de) * | 1984-12-14 | 1991-10-23 | Gergely, Gerhard, Dr. | Teilchen aus einer hydrophoben oder schwerlöslichen substanz und verfahren zu ihrer hydrophilisierung |
| NO873860L (no) * | 1986-10-31 | 1988-05-02 | Asta Pharma Ag | Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling. |
| US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
| EP0334083B1 (de) * | 1988-03-19 | 1991-07-24 | ASTA Pharma Aktiengesellschaft | Ifosfamid-Mesna-Lyophilisat und Verfahren zu dessen Herstellung |
| IE62095B1 (en) * | 1988-03-29 | 1994-12-14 | Univ Florida | Pharmaceutical formulations for parenteral use |
| WO1991004026A1 (en) * | 1989-09-14 | 1991-04-04 | Australian Commercial Research & Development Limited | Drug delivery compositions |
| US5227373A (en) * | 1991-10-23 | 1993-07-13 | Bristol-Myers Squibb Co. | Lyophilized ifosfamide compositions |
| ZA949182B (en) * | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
| DE19529057B4 (de) * | 1995-08-08 | 2007-12-13 | Baxter Healthcare S.A. | Ifosfamid-Lyophilisat-Zubereitungen |
| AUPQ849900A0 (en) | 2000-06-30 | 2000-07-27 | Dbl Australia Pty Ltd. | Injectable composition |
| US6906047B2 (en) | 2001-12-13 | 2005-06-14 | Gensia Sicor Pharmaceuticals, Inc. | Aqueous ifosfamide composition |
| KR101037313B1 (ko) * | 2002-09-05 | 2011-05-26 | 바라트 쎄럼스 앤드 백신스 리미티드 | 메스나를 함유하는 안정한 액체 옥스아자포스포린 조성물 |
| US7199111B2 (en) * | 2002-12-02 | 2007-04-03 | Bharat Serums & Vaccines Ltd. | Aqueous ifosfamide compositions for parenteral administration and a process for their preparations |
-
2003
- 2003-12-02 DE DE60332385T patent/DE60332385D1/de not_active Expired - Lifetime
- 2003-12-02 JP JP2004556751A patent/JP4611029B2/ja not_active Expired - Fee Related
- 2003-12-02 AT AT03808347T patent/ATE465744T1/de not_active IP Right Cessation
- 2003-12-02 NZ NZ540484A patent/NZ540484A/en not_active IP Right Cessation
- 2003-12-02 EP EP03808347A patent/EP1569663B1/de not_active Expired - Lifetime
- 2003-12-02 AU AU2003302579A patent/AU2003302579B2/en not_active Ceased
- 2003-12-02 CN CNB2003801094167A patent/CN100463678C/zh not_active Expired - Fee Related
- 2003-12-02 BR BR0316968-5A patent/BR0316968A/pt not_active IP Right Cessation
- 2003-12-02 KR KR1020057009953A patent/KR101066181B1/ko not_active Expired - Fee Related
- 2003-12-02 EA EA200500763A patent/EA012368B1/ru not_active IP Right Cessation
- 2003-12-02 WO PCT/IN2003/000376 patent/WO2004050012A2/en not_active Ceased
- 2003-12-02 CA CA002507848A patent/CA2507848A1/en not_active Abandoned
- 2003-12-02 MX MXPA05005919A patent/MXPA05005919A/es active IP Right Grant
- 2003-12-02 ES ES03808347T patent/ES2342380T3/es not_active Expired - Lifetime
-
2005
- 2005-05-29 IL IL168849A patent/IL168849A/en not_active IP Right Cessation
- 2005-05-31 ZA ZA200504437A patent/ZA200504437B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1744904A (zh) | 2006-03-08 |
| BR0316968A (pt) | 2005-10-25 |
| EP1569663A4 (de) | 2007-05-23 |
| ES2342380T3 (es) | 2010-07-06 |
| AU2003302579A1 (en) | 2004-06-23 |
| CA2507848A1 (en) | 2004-06-17 |
| MXPA05005919A (es) | 2005-09-21 |
| EP1569663A2 (de) | 2005-09-07 |
| WO2004050012A2 (en) | 2004-06-17 |
| EA200500763A1 (ru) | 2006-12-29 |
| CN100463678C (zh) | 2009-02-25 |
| KR20050089153A (ko) | 2005-09-07 |
| EP1569663B1 (de) | 2010-04-28 |
| IL168849A (en) | 2009-02-11 |
| NZ540484A (en) | 2008-03-28 |
| WO2004050012A3 (en) | 2004-10-21 |
| DE60332385D1 (de) | 2010-06-10 |
| ZA200504437B (en) | 2006-07-26 |
| JP2006512329A (ja) | 2006-04-13 |
| KR101066181B1 (ko) | 2011-09-20 |
| JP4611029B2 (ja) | 2011-01-12 |
| EA012368B1 (ru) | 2009-10-30 |
| AU2003302579B2 (en) | 2008-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| EA200501268A1 (ru) | Ингибирующие вич 1,2,4-триазины | |
| TNSN05194A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
| MXPA06011327A (es) | Azaindoles utiles como inhibidores de jak y otras proteinas cinasas. | |
| IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
| WO2005004818A3 (en) | Heterocyclic compounds and their use as anticancer agents | |
| CY1112253T1 (el) | Ενωσεις διαμινοτριαζολιου χρησιμες ως αναστολεις κινασης πρωτεϊνης | |
| MXPA05007516A (es) | Derivados de hexahidropirazino[1,2-a]pirimidina -4, 7-diona sustituidos, metodo para producirlos y su uso como medicamentos. | |
| DE602004021472D1 (en) | Pyrimiidinverbindungen | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| WO2005030766A8 (en) | Phenyl - carboxamide compounds useful for treating pain | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| TW200634012A (en) | 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents | |
| MXPA06012640A (es) | Compuestos de morfolina. | |
| ATE533765T1 (de) | Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung | |
| WO2007100758A3 (en) | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same | |
| IL185539A0 (en) | Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method compositions containing same and use | |
| MY135850A (en) | Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use | |
| MX2007013624A (es) | Inhibidores de proteina cinasa. | |
| TW200714598A (en) | Urea derivatives, methods for their manufacture, and uses therefor | |
| MXPA05008902A (es) | Soluciones de drogas en mentol. | |
| TW200613279A (en) | New pesticides | |
| MY148254A (en) | Tartrate derivatives for use as coagulation factor ixa inhibitors | |
| ATE465744T1 (de) | Ifosfamid-zusammensetzungen zur parenteralen verabreichung und verfahren für ihre herstellung | |
| UA93529C2 (ru) | Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |